Source:http://linkedlifedata.com/resource/pubmed/id/16858678
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2006-10-2
|
pubmed:abstractText |
Multiple investigations of the effects of peroxisome proliferator-activated receptor gamma (PPARgamma) ligands on colon cancer have produced contradictory results. While some studies demonstrated increased numbers of colonic polyps in Apc(Min/+) mice treated with various thiazolidinedione (TZD) PPARgamma ligands, others reported amelioration of tumor multiplicity and progression in both Apc(Min/+) mice and in mice with chemically-induced colon cancer. Here, we addressed the role of PPARgamma in murine intestinal tumorigenesis using gene knockout methodology. We found that either heterozygous or homozygous intestinal-specific PPARgamma deficiency enhanced the number of Apc(Min/+) tumors in both the small intestine and colon, especially in the colon, where PPARgamma deficiency also modulated tumor incidence. Gender significantly affected tumor multiplicity independent of PPARgamma genotype. Female Apc(Min/+) mice developed more tumors in the small intestine and more tumors overall, whereas male Apc(Min/+) mice developed more tumors in the colon. Nevertheless, intestinal PPARgamma deficiency enhanced tumorigenesis irrespective of gender. Our results suggest that PPARgamma functions as a tumor resistance factor in the mouse intestine and warrant further investigation of the PPARgamma-dependent and independent actions of TZDs in cancer.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2339-46
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16858678-Animals,
pubmed-meshheading:16858678-Colonic Neoplasms,
pubmed-meshheading:16858678-Disease Progression,
pubmed-meshheading:16858678-Female,
pubmed-meshheading:16858678-Genes, APC,
pubmed-meshheading:16858678-Genotype,
pubmed-meshheading:16858678-Immunohistochemistry,
pubmed-meshheading:16858678-Intestinal Neoplasms,
pubmed-meshheading:16858678-Male,
pubmed-meshheading:16858678-Mice,
pubmed-meshheading:16858678-Mice, Knockout,
pubmed-meshheading:16858678-PPAR gamma,
pubmed-meshheading:16858678-Phenotype,
pubmed-meshheading:16858678-Sex Factors,
pubmed-meshheading:16858678-Thiazoles,
pubmed-meshheading:16858678-Thiazolidines
|
pubmed:year |
2006
|
pubmed:articleTitle |
Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMin/+ mice.
|
pubmed:affiliation |
Department of Biochemistry and Molecular Biology, University of Minnesota Medical School, Duluth, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|